Dyne Therapeutics, Inc. (DYN)
15.44
+0.24
(+1.58%)
USD |
NASDAQ |
Oct 05, 16:00
15.44
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Net Income (Quarterly) : -178.56M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -178.56M |
| March 31, 2026 | -120.85M |
| December 31, 2025 | -111.96M |
| September 30, 2025 | -108.04M |
| June 30, 2025 | -110.86M |
| March 31, 2025 | -115.36M |
| December 31, 2024 | -89.54M |
| September 30, 2024 | -97.12M |
| June 30, 2024 | -65.10M |
| March 31, 2024 | -65.65M |
| December 31, 2023 | -66.64M |
| September 30, 2023 | -60.21M |
| June 30, 2023 | -64.90M |
| Date | Value |
|---|---|
| March 31, 2023 | -44.19M |
| December 31, 2022 | -38.83M |
| September 30, 2022 | -41.38M |
| June 30, 2022 | -52.30M |
| March 31, 2022 | -35.58M |
| December 31, 2021 | -51.79M |
| September 30, 2021 | -42.58M |
| June 30, 2021 | -29.96M |
| March 31, 2021 | -24.97M |
| December 31, 2020 | -28.65M |
| September 30, 2020 | -13.92M |
| December 31, 2019 | -5.403M |
| September 30, 2019 | -5.871M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 144.40M |
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 178.56M |
| EPS Diluted (Quarterly) | -1.079 |
| Enterprise Value | 1.893B |
| Earnings Yield | -21.58% |
| Normalized Earnings Yield | -21.58 |